Before giving written consent, the person concerned is informed of the characteristics of the disease under investigation, the means of detecting it, the degree of reliability of the analyses and the possibilities for prevention and treatment. They will also be informed of the genetic transmission of the disease under investigation and the possible consequences for other members of their family.
The information mentioned in the previous paragraph is brought to the attention of the trusted support person, the family or a close relative when these persons are consulted in application of the second paragraph of article L. 1131-1.
Where the person concerned is a minor or an adult under guardianship, consent is given, under the conditions of the first paragraph, by the holders of parental authority or the legal representative. In addition, the consent of the minor or adult under guardianship is systematically sought if he or she is capable of expressing his or her wishes and participating in the decision.